THURSDAY, Nov. 13, 2025 — The U.S. Food and Drug Administration (FDA) has appointed one of its most respected cancer drug regulators to lead the agency’s main division for approving new drugs.
The appointment of Dr. Richard Pazdur comes…
Blog
Leave a Reply